Horizon Pharma Plc.'s ticker is and the CUSIP is 00BQPVQZ6. A total of 1 filers reported holding Horizon Pharma Plc. in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,256,698 | -0.4% | 36,794 | -11.5% | 0.02% | 0.0% |
| Q2 2023 | $4,275,680 | -6.6% | 41,572 | -0.9% | 0.02% | -13.8% |
| Q1 2023 | $4,576,895 | -9.5% | 41,936 | -5.6% | 0.03% | -19.4% |
| Q4 2022 | $5,055,906 | -100.0% | 44,428 | -95.6% | 0.04% | -92.6% |
| Q3 2022 | $62,857,836,000 | -6.9% | 1,015,638 | +20.0% | 0.48% | +2.1% |
| Q2 2022 | $67,498,575,000 | -20.9% | 846,271 | +4.3% | 0.48% | -6.5% |
| Q1 2022 | $85,381,703,000 | +22.4% | 811,536 | +25.4% | 0.51% | +24.2% |
| Q4 2021 | $69,758,975,000 | +241.2% | 647,355 | +246.8% | 0.41% | +207.5% |
| Q3 2021 | $20,446,408,000 | +23.9% | 186,657 | +5.9% | 0.13% | +22.0% |
| Q2 2021 | $16,500,211,000 | +13.3% | 176,209 | +11.4% | 0.11% | +2.8% |
| Q1 2021 | $14,561,464,000 | +582.0% | 158,208 | +442.0% | 0.11% | +457.9% |
| Q4 2020 | $2,135,249,000 | – | 29,190 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DnB Asset Management AS | 44,428 | $5,055,906 | 0.04% |